PMFA
DERM icon

Plante Moran Financial Advisors’s Journey Medical DERM Stock Holding History

Plante Moran Financial Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-200
Closed -$1K – 988
2022
Q1 		$1K Buy
+200
New +$998 ﹤0.01% 773

Other funds holding DERM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $85.5M AUM 3.46% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Plante Moran Financial Advisors's DERM Position: Q2 2022 in Review

Plante Moran Financial Advisors sold out of Journey Medical (DERM) in Q2 2022, closing a stake of 200 shares — an estimated $1K sold.

Plante Moran Financial Advisors first reported a position in DERM in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 13 funds tracked by Wall St. Rank hold DERM as of Q2 2022.

  • Plante Moran Financial Advisors reported no remaining Journey Medical position as of Q2 2022 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 200 Journey Medical shares in Q2 2022, an estimated $1K.
  • Plante Moran Financial Advisors first reported a position in Journey Medical in Q1 2022 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Journey Medical position peaked at $1K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Journey Medical as of Q2 2022.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.